Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.02 |
mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.27 | 0.02 |
mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |